Cargando…
Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649945/ https://www.ncbi.nlm.nih.gov/pubmed/31433399 http://dx.doi.org/10.1093/rap/rky037 |
| _version_ | 1783438078627545088 |
|---|---|
| author | Yahya, Fariz Gaffney, Karl Hamilton, Louise Lonsdale, Ellie Leeder, Jane Brooksby, Alan Cavill, Charlotte Berry-Jenkins, Joshua Boyle, Cathal Bond, Debbie Sengupta, Raj |
| author_facet | Yahya, Fariz Gaffney, Karl Hamilton, Louise Lonsdale, Ellie Leeder, Jane Brooksby, Alan Cavill, Charlotte Berry-Jenkins, Joshua Boyle, Cathal Bond, Debbie Sengupta, Raj |
| author_sort | Yahya, Fariz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6649945 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66499452019-08-20 Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply Yahya, Fariz Gaffney, Karl Hamilton, Louise Lonsdale, Ellie Leeder, Jane Brooksby, Alan Cavill, Charlotte Berry-Jenkins, Joshua Boyle, Cathal Bond, Debbie Sengupta, Raj Rheumatol Adv Pract Letter to the Editor (matters arising from published papers) Oxford University Press 2018-10-18 /pmc/articles/PMC6649945/ /pubmed/31433399 http://dx.doi.org/10.1093/rap/rky037 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor (matters arising from published papers) Yahya, Fariz Gaffney, Karl Hamilton, Louise Lonsdale, Ellie Leeder, Jane Brooksby, Alan Cavill, Charlotte Berry-Jenkins, Joshua Boyle, Cathal Bond, Debbie Sengupta, Raj Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply |
| title | Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply |
| title_full | Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply |
| title_fullStr | Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply |
| title_full_unstemmed | Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply |
| title_short | Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply |
| title_sort | comment on: tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a united kingdom cohort: reply |
| topic | Letter to the Editor (matters arising from published papers) |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649945/ https://www.ncbi.nlm.nih.gov/pubmed/31433399 http://dx.doi.org/10.1093/rap/rky037 |
| work_keys_str_mv | AT yahyafariz commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT gaffneykarl commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT hamiltonlouise commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT lonsdaleellie commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT leederjane commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT brooksbyalan commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT cavillcharlotte commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT berryjenkinsjoshua commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT boylecathal commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT bonddebbie commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply AT senguptaraj commentontumournecrosisfactorinhibitorsurvivalandpredictorsofresponseinaxialspondyloarthritisfindingsfromaunitedkingdomcohortreply |